NVS

Authorities to Raid Novartis Offices Over Fake Drug Data

Japanese media reports say that regulators will conduct on-site investigations at Novartis offices in Japan over claims that drug study data was faked. More 

Veeva Systems: 2013′s Can’t-Miss IPO

Veeva Systems operates at the crossroads of two red-hot industries -- the cloud and biotech -- and could be the year's hottest IPO. More 

3 Healthcare Stocks With Healthy Dividends

Protect yourself from the headwinds facing healthcare stocks by snatching up names that offer -- and are likely to keep offering -- big-time dividends. More 

3 Super-Cheap ETFs to Buy Now

One of the best ways to supercharge your profits over the long-term is to focus on low-cost ETFs, which help you keep more returns. More 

If Not Amgen, Who’s Next in Line to Buy Onyx?

A few larger players could make attractive suitors for Onyx Pharmaceuticals and its cancer drugs, but the key is whether they'll trump an already frothy bid More 

15 Dividend Stocks to Buy on the Cheap

Here are 15 dividend stocks that I find a great value today based on our fundamental analysis. All provide great yields and solid growth potential More 

Former Ad Agency Receptionist Now CEO

Karen Kaplan was just named the CEO of ad agency Hill Holliday just over thirty years after being hired as a receptionist there. More